Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Inventory: 2022-2024

Historic Inventory for Whitehawk Therapeutics (WHWK) over the last 3 years, with Dec 2024 value amounting to $5.3 million.

  • Whitehawk Therapeutics' Inventory fell 17.36% to $5.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.3 million, marking a year-over-year decrease of 17.36%. This contributed to the annual value of $5.3 million for FY2024, which is 17.36% down from last year.
  • Per Whitehawk Therapeutics' latest filing, its Inventory stood at $5.3 million for FY2024, which was down 17.36% from $6.4 million recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Inventory ranged from a high of $6.4 million in FY2023 and a low of $1.9 million during FY2022.
  • Its 3-year average for Inventory is $4.5 million, with a median of $5.3 million in 2024.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Inventory skyrocketed by 245.35% in 2023, and later fell by 17.36% in 2024.
  • Yearly analysis of 3 years shows Whitehawk Therapeutics' Inventory stood at $1.9 million in 2022, then soared by 245.35% to $6.4 million in 2023, then dropped by 17.36% to $5.3 million in 2024.